Unlock instant, AI-driven research and patent intelligence for your innovation.

T cell capable of improving immune response, and preparation method and application thereof

A technology of immune response and immune cells, applied in the field of T cells, can solve the problems of high cost of treatment, chronic viral infection and bacterial infection without treatment methods, etc., and achieve the effect of rapid self-proliferation and high expression

Inactive Publication Date: 2020-06-09
GUANGZHOU BRIGHT MEDICAL TECH
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] In summary, tumors, chronic viral infections (such as HIV, HBV), and bacterial infections (such as Mycobacterium tuberculosis, superbugs) currently have no effective treatments, and the treatment costs are expensive

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • T cell capable of improving immune response, and preparation method and application thereof
  • T cell capable of improving immune response, and preparation method and application thereof
  • T cell capable of improving immune response, and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Embodiment 1, preparation carries the retrovirus expression plasmid of exogenous gene

[0040] 1. Construction of clones: (1) Total RNA was extracted from mouse splenocytes and DC cells (dendritic cells), and used as a cDNA library after reverse transcription. (2) Use the cDNA library as a template to amplify CD40L and 4-1BBL sequences by PCR, use Migr1 as a carrier to amplify the IERS sequence by PCR, and use the 2A sequence synthesized by the company as a template to amplify the 2A sequence by PCR. In this step:

[0041] Primers used in PCR amplification include:

[0042]

[0043] The PCR amplification system is:

[0044]

[0045]

[0046] The procedure used for PCR amplification is:

[0047]

[0048] CD40L sequence (SEQ ID No.19), 4-1BBL sequence (SEQ ID No.20) (see figure 1 ) are as follows:

[0049] SEQ ID No. 19:

[0050] ATGATAGAAACATACAGCCAACCTTCCCCCAGATCCGTGGCAACTGGACTTCCAGCGAGCATGAAGATTTTTATGTATTTACTTACTGTTTTCCTTATCACCCAAATGATTGGATCTGTGCTTT...

Embodiment 2

[0076] Embodiment 2, in OT-I CD8 + T cell surface expresses CD40L and 4-1BBL

[0077] a. 293T is passaged and plated, and the retrovirus is packaged, as in Example 1.

[0078] b. Spleen cells were isolated from 6- to 8-week-old OT-I mice and activated by adding N4.

[0079] c. 24h later, the activated OT-I CD8 was transduced with different retroviruses carrying foreign genes + T cells:

[0080] Treatment ①: The activated OT-I CD8 was transduced with a retrovirus carrying the exogenous gene CD40L alone + T cells;

[0081] Treatment ②: transduction of activated OT-I CD8 with retrovirus carrying foreign gene 4-1BBL alone + T cells;

[0082] Treatment ③ transduction of activated OT-I CD8 with retrovirus carrying exogenous gene 4-1BBL-2A-CD40L + T cells;

[0083] Treatment ④: transduction of activated OT-I CD8 with retrovirus carrying exogenous gene 4-1BBL-IRES-CD40L + T cells;

[0084] Treatment ⑤: transduction of activated OT-I CD8 with retrovirus carrying exogenous g...

Embodiment 3

[0093] Embodiment 3, in OT-I CD8 + Detection of cell proliferation after expressing CD40L and 4-1BBL on the surface of T cells

[0094] a. Take OT-I mice aged 6-8 weeks, separate spleen cells and add N4 to stimulate culture.

[0095] b. OT-I CD8 that will be activated after 24h + T cells are evenly divided, and the CD8 cells activated are respectively transduced with different viruses obtained in Example 1. + T cells.

[0096] c. After another 24 hours, CD8 + T cells are collected and counted under a microscope. Operation process see Figure 11 a.

[0097] For test results, see Figure 11 b. Overexpression of CD40L can promote cell proliferation compared with the control, but there is no statistical difference. Overexpression of 4-1BBL can effectively promote cell proliferation, and the auxiliary effect is stronger when overexpressing 4-1BBL and CD40L at the same time, indicating that 4-1BBL and CD40L have a mutual superimposed effect in promoting cell proliferation...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a T cell capable of improving immune response, and a preparation method and application thereof. The T cell capable of improving the immune response is prepared by integratingan exogenous gene 4-1BBL onto chromosomes of an antigen-specific T cell for overexpression. The T cell capable of improving the immune response has the advantages of fast proliferation, high expression quantity of IFN-gamma, is especially capable of remarkably promoting the proliferation and IFN-gamma expression levels of antigen-specific T cells surrounding the T cell capable of improving the immune response and carrying no exogenous gene, functions as a general in the aspect of activating the immune response capability of the surrounding antigen-specific T cells, and plays a critical role in treatment of tumors, chronic virus infections and bacterial infections.

Description

technical field [0001] The invention relates to the technical field of T cells, in particular to T cells capable of improving immune response, a preparation method and application thereof. Background technique [0002] The T cell therapy technologies currently used to improve the body's immunity include expanded T cell therapy technology, CAR-T cell therapy technology and TCR-T cell therapy technology. The first technique is to simply expand a large number of patient-specific cells for treatment without substantial changes in T cell function. CAR-T and TCR-T cell therapy technology is to enhance the ability to recognize tumors or viruses by expressing artificially modified or screened T cell receptors, so as to achieve the purpose of eliminating viruses and tumors. None of the three existing T-cell therapy technologies can enhance the function of other immune cells in the body that have not been engineered, and thus are ineffective against chronic viral infections and solid...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K35/17A61P37/04A61P35/00A61P31/12A61P31/04A61P31/10
CPCA61K35/17A61P37/04A61P35/00A61P31/12A61P31/04A61P31/10
Inventor 冷启彬张朔黄狄文
Owner GUANGZHOU BRIGHT MEDICAL TECH